flow trial semaglutide kidney outcomes results 2024 LANDMARK ALERT 🚨 REPRIEVE Trial results: Pitavastatin provides over 35% reduction in MACE in patients with HIV! Get With the FLOW! in:

If gastric ultrasound facilities and/or expertise is not available, patients on GLP-1RAs should be treated as unfasted and precautions taken to prevent pulmonary aspiration such as protecting the airway with endotracheal intubation

Multiple significant peaks indicate synthesis errors, degradation products, or contamination

Wegovy is prescribed for adults with a body mass index (BMI) of 30 kg/m or greater or for those with a BMI of 27 kg/m or greater who have at least one weight-related comorbidity (such as type 2 diabetes, high blood pressure, or high cholesterol)

Other notable areas include C12N and C12Y , which describe the use of engineered microorganisms involved in drug production and enzymes, respectively

Nausea rates in retatrutides Phase 2 trial were dose-dependent, reaching approximately 20-25% at the 12 mg dose level

Research findings are summarized in a new Quick Take video